2.Hepatocyte growth factor and its immunoregulatory activity - review.
Li BIAN ; Zi-Kuan GUO ; Hui-Sheng AI
Journal of Experimental Hematology 2007;15(2):441-444
Hepatocyte growth factor (HGF) is a pleiotropic cytokine, its roles in the physiology and pathology of immune system, have been investigated thoroughly, great deal of data have been documented on its immunoregulatory activity. In this review, according to advance of study on HGF in recent years, the role of HGF in the immune regulation, such as immunoregulatory effects of HGF on T lymphocytes, B lymphocytes and dendritic cell, modulation of HGF on specific humoral and cellular immune response, control of acute GVHD and acceleration of myeloid and immunologic reconstitution in allogenetic bone marrow transplantation models, promotion of tissue repair and regeneration, and alleviation of immune rejection in allogeneic organ transplantation including the heart, liver and kidney transplantation, prevention of grafts from injury as well as applicably useful of HGF in the therapy of autoimmune disorders were summarized.
Animals
;
Graft Rejection
;
immunology
;
prevention & control
;
Graft vs Host Disease
;
immunology
;
prevention & control
;
Graft vs Leukemia Effect
;
immunology
;
Hepatocyte Growth Factor
;
physiology
;
Humans
;
Immunity, Cellular
;
immunology
3.Single-lung transplantation for end-stage emphysema.
Jing-yu CHEN ; Ming-feng ZHENG ; Yi-jun HE ; Qian-kun ZHU ; Chun-xiao HU ; Ruo CHEN ; Da-wei ZHU ; Zheng-xing SU ; Shu-gao YE
Chinese Journal of Surgery 2003;41(6):404-406
OBJECTIVETo evaluate operative technique, patient selection and perioperative management of single-lung transplantation for a patients with end-stage emphysema.
METHODSA 56-year-old patient with end-stage emphysema underwent left-lung transplantation on September 28, 2002. The surgical technique used was similar to that mentioned in the literature. The donor lung was perfused by LPD solution with a cold ischemic time of 260 minutes. Cardiopulmonary bypass was not performed.
RESULTSThe patient weaned from a ventilator at the 93th hour after operation. Immunosuppressants included cyclosporine, mycophenolate mofetil and corticosteroid. Acute rejection occurred on the ninth day after operation and was cured by bolus methylprednisolone given intravenously. Lung function was improved significantly and the patient was discharged from the hospital on the 47th day after operation.
CONCLUSIONSingle-lung transplantation for patients with end-stage emphysema is effective for long-term improvement of pulmonary function.
Adult ; Emphysema ; surgery ; Graft Rejection ; prevention & control ; Humans ; Lung Transplantation ; methods ; Male ; Middle Aged
4.Pig islets for islet xenotransplantation: current status and future perspectives.
Qinghua HU ; Zhongwei LIU ; Haitao ZHU
Chinese Medical Journal 2014;127(2):370-377
OBJECTIVETo review the current status and progress on pig islet xenotransplantation.
DATA SOURCESData used in this review were mainly from English literature of Pubmed database. The search terms were "pig islet" and "xenotransplantation".
STUDY SELECTIONThe original articles and critical reviews selected were relevant to this review's theme.
RESULTSPigs are suggested to be an ideal candidate for obtaining available islet cells for transplantation. However, the potential clinical application of pig islet is still facing challenges including inadequate yield of high-quality functional islets and xenorejection of the transplants. The former can be overcome mainly by selection of a suitable pathogen-free source herd and the development of isolation and purification technology. While the feasibility of successful preclinical pig islet xenotranplantation provides insights in the possible mechanisms of xenogeneic immune recognition and rejection to overwhelm the latter. In addition, the achievement of long-term insulin independence in diabetic models by means of distinct islet products and novel immunotherapeutic strategies is promising.
CONCLUSIONSPig islet xenotransplantation is one of the prospective treatments to bridge the gap between the needs of transplantation in patients with diabetes and available islet cells. Nonetheless, further studies and efforts are needed to translate obtained findings into tangible applications.
Animals ; Graft Rejection ; immunology ; prevention & control ; Islets of Langerhans Transplantation ; immunology ; methods ; Swine ; Transplantation, Heterologous ; methods
6.Minimization or avoidance of calcineurin inhibitors after renal transplantation.
Acta Academiae Medicinae Sinicae 2009;31(3):280-283
Calcineurin inhibitors (CNIs) are playing an important role in preventing acute rejection in renal transplantation; however, their nephrotoxicity may impact long-term renal allograft survival. Several CNI-sparing regimens (such as CNI-avoidance or CNI-minimization) have shown at least comparable efficacy with standard-dose CNI regimens. Research continues to achieve the "best" balance between efficacy and toxicity of available immunosuppressive regimens.
Calcineurin Inhibitors
;
Graft Rejection
;
prevention & control
;
Humans
;
Immunosuppressive Agents
;
administration & dosage
;
adverse effects
;
Kidney Transplantation
8.Ipsilateral lymphadenectomy to inhibit corneal allograft rejection in rats.
Journal of Huazhong University of Science and Technology (Medical Sciences) 2005;25(1):88-90
In order to investigate the ipsilateral lymphadenectomy for inhibiting rejection in rat corneal transplantation, corneal allogenic transplantation models were established in rats. Eighteen female Wister rats were used as donors, and 36 Sprague Dawley rats as recipients. After penetrating corneal transplantation, recipients were randomly divided into 3 groups: group A (control group); group B, the ipsilateral lymphadenectomy group; group C, the bilateral lymphadenectomy group. Among 12 rats in each group, the corneas of 2 rats in each group were used for pathological study at day 14 after the transplantation, and the remaining 10 rats were used for studying corneal rejection by a slit lamp. The time points when allograft rejection occurred were recorded and mean survival time (MST) was compared. The results showed that MST in groups B and C was 46.30 +/- 9. 464 days and 44.43 +/- 7. 604 days, respectively, which was significantly prolonged as compared with that in group A (10.71 +/- 1.567 days, P < 0.01). There was no significant difference in MST between groups B and C (P > 0.05). It was concluded that both bilateral and ipsilateral lymphadenectomy therapies could effectively inhibit the corneal allograft rejection. Ipsilateral lymphadenectomy is a less complex surgical procedure and is just as effective in preventing rejection.
Corneal Transplantation
;
Graft Rejection/*prevention & control
;
Graft Survival
;
Lymph Node Excision/*methods
;
Random Allocation
;
Rats, Sprague-Dawley
;
Rats, Wistar
9.Gut microbial balance and liver transplantation: alteration, management, and prediction.
Xinyao TIAN ; Zhe YANG ; Fangzhou LUO ; Shusen ZHENG
Frontiers of Medicine 2018;12(2):123-129
Liver transplantation is a conventional treatment for terminal stage liver diseases. However, several complications still hinder the survival rate. Intestinal barrier destruction is widely observed among patients receiving liver transplant and suffering from ischemia-reperfusion or rejection injuries because of the relationship between the intestine and the liver, both in anatomy and function. Importantly, the resulting alteration of gut microbiota aggravates graft dysfunctions during the process. This article reviews the research progress for gut microbial alterations and liver transplantation. Especially, this work also evaluates research on the management of gut microbial alteration and the prediction of possible injuries utilizing microbial alteration during liver transplantation. In addition, we propose possible directions for research on gut microbial alteration during liver transplantation and offer a hypothesis on the utilization of microbial alteration in liver transplantation. The aim is not only to predict perioperative injuries but also to function as a method of treatment or even inhibit the rejection of liver transplantation.
Animals
;
Gastrointestinal Microbiome
;
Graft Rejection
;
prevention & control
;
Humans
;
Intestinal Mucosa
;
physiopathology
;
ultrastructure
;
Liver Transplantation
;
Rats
;
Reperfusion Injury
;
prevention & control